AFT Forsyth & Company’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-20,000
Closed -$152K 137
2019
Q4
$152K Hold
20,000
0.12% 141
2019
Q3
$98K Hold
20,000
0.08% 134
2019
Q2
$81K Hold
20,000
0.07% 142
2019
Q1
$70K Buy
20,000
+5,000
+33% +$17.5K 0.06% 139
2018
Q4
$27K Buy
+15,000
New +$83.2K 0.03% 135

Other funds holding MDXG

AFT Forsyth & Company's MDXG Position: Q1 2020 in Review

AFT Forsyth & Company sold out of MiMedx Group (MDXG) in Q1 2020, closing a stake of 20,000 shares — an estimated $152K sold.

AFT Forsyth & Company first reported a position in MDXG in Q4 2018 and held it in 5 quarters. The position peaked at $152K in Q4 2019. 22 funds tracked by Wall St. Rank hold MDXG as of Q1 2020.

  • AFT Forsyth & Company reported no remaining MiMedx Group position as of Q1 2020 after selling out during the quarter.
  • AFT Forsyth & Company sold 20,000 MiMedx Group shares in Q1 2020, an estimated $152K.
  • AFT Forsyth & Company first reported a position in MiMedx Group in Q4 2018 and held it in 5 quarters.
  • AFT Forsyth & Company's MiMedx Group position peaked at $152K in Q4 2019.
  • 22 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2020.

Based on AFT Forsyth & Company's 13F filing for Q1 2020, filed 11 May 2020.